retatrutide vs triple agonist — genuinely asking which matters more
Posting this because I searched for it and got nothing useful. Setup: 1.7mg, week 30, sulphur burps present but not ruining anything. I changed exactly one variable — dose escalation — and tracked it for 22 weeks. Result: a difference, but a small one, and well inside what I would call noise if someone else posted…
Inter-lab variance on this kind of assay is routinely 1–2 points. Different column, different gradient, different integration.
Inter-lab variance on this kind of assay is routinely 1–2 points.
Disagree on that part. 98.4% and 98.3% on the same vial is normal.
Inter-lab variance on this kind of assay is routinely 1–2 points.
Disagree on that part. 97.9% and 97.6% on the same vial is normal.
Are you quoting phase 2 or is there phase 3 data now?